Writers, Readers and Erasers of RNA Modifications in Cancer.

[1]  Nakul M. Shah,et al.  Crosstalk between the RNA Methylation and Histone-Binding Activities of MePCE Regulates P-TEFb Activation on Chromatin. , 2018, Cell reports.

[2]  Ling-Zhi Wang,et al.  Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer , 2013, EMBO molecular medicine.

[3]  Michaela Frye,et al.  Stem cell function and stress response are controlled by protein synthesis , 2016, Nature.

[4]  R. Lothe,et al.  Identification of Novel Fusion Genes in Testicular Germ Cell Tumors. , 2016, Cancer research.

[5]  H. Zhe,et al.  FTO regulates the chemo‐radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β‐catenin through mRNA demethylation , 2018, Molecular carcinogenesis.

[6]  Samir Adhikari,et al.  5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.

[7]  E. Kool,et al.  Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker. , 2016, Journal of the American Chemical Society.

[8]  Dan Xie,et al.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.

[9]  F. Rottman,et al.  Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. , 1994, The Journal of biological chemistry.

[10]  J. Taylor,et al.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Job,et al.  Genomic Aberrations in Lung Adenocarcinoma in Never Smokers , 2010, PloS one.

[12]  F. Setién,et al.  Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer , 2019, Oncogene.

[13]  Akihiro Kuno,et al.  TRMT2A is a novel cell cycle regulator that suppresses cell proliferation. , 2019, Biochemical and biophysical research communications.

[14]  Wengong Wang,et al.  Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer , 2016, Oncotarget.

[15]  R Engers,et al.  DKC1 overexpression associated with prostate cancer progression , 2009, British Journal of Cancer.

[16]  T. Ishiwata,et al.  Elevated expression level of 60-kDa subunit of tRNA-guanine transglycosylase in colon cancer. , 2004, Cancer letters.

[17]  J. Nadeau,et al.  Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors. , 2017, Cancer research.

[18]  Y. Jaiswal,et al.  Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer , 2008 .

[19]  Zhike Lu,et al.  m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.

[20]  Sebastian A. Leidel,et al.  Codon-specific translation reprogramming promotes resistance to targeted therapy , 2018, Nature.

[21]  Chao Xu,et al.  YTH Domain: A Family of N6-methyladenosine (m6A) Readers , 2018, Genom. Proteom. Bioinform..

[22]  Seung-Yong Jeong,et al.  RNA editing in RHOQ promotes invasion potential in colorectal cancer , 2014, The Journal of experimental medicine.

[23]  Y. Liu,et al.  FTO expression is associated with the occurrence of gastric cancer and prognosis. , 2017, Oncology reports.

[24]  John G Doench,et al.  Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade , 2018, Nature.

[25]  Tomasz K. Wirecki,et al.  MODOMICS: a database of RNA modification pathways. 2017 update , 2017, Nucleic Acids Res..

[26]  P. Pandolfi,et al.  Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program , 2019, Acta Neuropathologica.

[27]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[28]  G. Kong,et al.  Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. , 2006, Biomedical chromatography : BMC.

[29]  L. Crinò,et al.  DKC1 gene mutations in human sporadic cancer. , 2013, Histology and histopathology.

[30]  이화영.  X , 1960, Chinese Plants Names Index 2000-2009.

[31]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[32]  J. Cerhan,et al.  Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients. , 2015 .

[33]  Xiandong Lin,et al.  Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population. , 2013, Carcinogenesis.

[34]  Jie Jin,et al.  FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.

[35]  J. Steitz,et al.  Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA , 2016, Proceedings of the National Academy of Sciences.

[36]  Yuen Gao,et al.  HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. , 2018, Cancer letters.

[37]  F. Du,et al.  YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells , 2017, Cell cycle.

[38]  Marcin Feder,et al.  MODOMICS: a database of RNA modification pathways , 2005, Nucleic Acids Res..

[39]  A. Karamyshev,et al.  Lost in Translation: Ribosome-Associated mRNA and Protein Quality Controls , 2018, Front. Genet..

[40]  Lingeng Lu,et al.  Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival. , 2017, Future oncology.

[41]  U. Pastorino,et al.  Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer , 2005, Oncogene.

[42]  L. Ellis,et al.  APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. , 2011, The Journal of clinical investigation.

[43]  M. Esteller,et al.  SnapShot: Messenger RNA Modifications , 2018, Cell.

[44]  S. Chambers,et al.  Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. , 2019, Biochimica et biophysica acta. Gene regulatory mechanisms.

[45]  Yuan Ren,et al.  Overexpression of TRMT12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma , 2019, OncoTargets and therapy.

[46]  Chuan He,et al.  Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. , 2019, Molecular cell.

[47]  Chuan He,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[48]  J. Tainer,et al.  Human ABH3 structure and key residues for oxidative demethylation to reverse DNA/RNA damage , 2006, The EMBO journal.

[49]  Andrew J. Bannister,et al.  METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation , 2019, Molecular cell.

[50]  Chuan He,et al.  Anti-tumor immunity controlled through mRNA m6A and YTHDF1 in dendritic cells , 2019, Nature.

[51]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[52]  M. Schaefer,et al.  Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. , 2009, Cancer research.

[53]  Jun Chen,et al.  METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN , 2019, Journal of Molecular Medicine.

[54]  Fedorov Na,et al.  Urinary excretion of purine bases and pseudouridine normal human and in cancer patients before and after radiotherapy. 1 , 1969 .

[55]  Yusuke Nakamura,et al.  A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. , 2005, Cancer research.

[56]  Zhike Lu,et al.  m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade , 2019, Nature Communications.

[57]  Richard L. Mercer,et al.  WHERE Ω , 1973, APLQ.

[58]  Tao Pan,et al.  Dynamic RNA Modifications in Gene Expression Regulation , 2017, Cell.

[59]  Yue Sheng,et al.  METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. , 2017, Cell stem cell.

[60]  K. Shimada,et al.  PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis. , 2012, Cancer research.

[61]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[62]  W. Cohn,et al.  Some results of the applications of ion-exchange chromatography to nucleic acid chemistry. , 1951, Journal of cellular physiology. Supplement.

[63]  F. Setién,et al.  Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia , 2017, Leukemia.

[64]  T. Jensen,et al.  Escaping nuclear decay: the significance of mRNA export for gene expression , 2018, Current Genetics.

[65]  O. Abdel-Wahab,et al.  Altered RNA Processing in Cancer Pathogenesis and Therapy. , 2019, Cancer discovery.

[66]  Yanli Gu,et al.  CDK5RAP1 targeting NF-κB signaling pathway in human malignant melanoma A375 cell apoptosis , 2018, Oncology letters.

[67]  Chuan He,et al.  m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer , 2018, Nature Cell Biology.

[68]  A. Dutra,et al.  Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer , 2007, Genes, chromosomes & cancer.

[69]  Francine E. Garrett-Bakelman,et al.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells , 2017, Nature Medicine.

[70]  P. Pandolfi,et al.  The Epitranscriptome of Noncoding RNAs in Cancer. , 2017, Cancer discovery.

[71]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[72]  Li Wei,et al.  CDK5RAP1 deficiency induces cell cycle arrest and apoptosis in human breast cancer cell line by the ROS/JNK signaling pathway. , 2015, Oncology reports.

[73]  M. Öhman,et al.  ADAR1 Editing and its Role in Cancer , 2018, Genes.

[74]  Lai Wei,et al.  RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2 , 2018, Hepatology.

[75]  Thomas de Quincey.  [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.

[76]  P. Alam.  ‘G’ , 2021, Composites Engineering: An A–Z Guide.

[77]  Sebastian A. Leidel,et al.  Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer , 2016, The Journal of experimental medicine.

[78]  Chuanzhao Zhang,et al.  Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA , 2016, Proceedings of the National Academy of Sciences.

[79]  David N. Rider,et al.  Germline predictors of androgen deprivation therapy response in advanced prostate cancer. , 2012, Mayo Clinic proceedings.

[80]  Yang Shi,et al.  m6A RNA methylation regulates the UV-induced DNA damage response , 2016, Nature.

[81]  Joseph,et al.  Characterization and Partial Purification of mRNA NG-Adenosine Methyltransferase from HeLa Cell Nuclei , 2001 .

[82]  James E. Bradner,et al.  R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling , 2018, Cell.

[83]  Wen-He Huang,et al.  Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas , 2012, PloS one.

[84]  X. Zuo,et al.  RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer , 2017, Proceedings of the National Academy of Sciences.

[85]  D. Tenen,et al.  ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. , 2016, Gastroenterology.

[86]  F. Watt,et al.  The RNA Methyltransferase Misu (NSun2) Mediates Myc-Induced Proliferation and Is Upregulated in Tumors , 2006, Current Biology.

[87]  F. Setién,et al.  Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis , 2015, Oncogene.

[88]  John S. Mattick,et al.  The RNA modification landscape in human disease , 2017, RNA.

[89]  C. Cho,et al.  m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer , 2019, Translational oncology.

[90]  P. Alam.  ‘V’ , 2021, Composites Engineering: An A–Z Guide.

[91]  Lv-yun Zhu,et al.  Spatial organization of enzymes to enhance synthetic pathways in microbial chassis: a systematic review , 2018, Microbial Cell Factories.

[92]  J. Clohessy,et al.  Dyskerin expression influences the level of ribosomal RNA pseudo‐uridylation and telomerase RNA component in human breast cancer , 2006, The Journal of pathology.

[93]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[94]  Bifeng Yuan,et al.  ALKBH1 demethylates N3-methylcytidine in mRNA of mammals. , 2019, ACS chemical biology.

[95]  Kaori Takai,et al.  RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. , 2016, Cancer letters.

[96]  N. Fedorov,et al.  [Urinary excretion of purine bases and pseudouridine normal human and in cancer patients before and after radiotherapy. 1]. , 1969, Radiobiologia, radiotherapia.

[97]  S. Robson,et al.  Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing , 2012, Cell.

[98]  Schraga Schwartz,et al.  Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites. , 2014, Cell reports.

[99]  P. Alam.  ‘L’ , 2021, Composites Engineering: An A–Z Guide.

[100]  Chuan He,et al.  RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia , 2018, Nature Communications.

[101]  Peter Kraft,et al.  Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. , 2016, Cancer discovery.

[102]  A. Muñoz-Barrutia,et al.  Multiscale in situ analysis of the role of dyskerin in lung cancer cells. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[103]  John E. J. Rasko,et al.  Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia , 2017, Journal of Hematology & Oncology.

[104]  M. McNutt,et al.  GSK-3β–Regulated N-Acetyltransferase 10 Is Involved in Colorectal Cancer Invasion , 2014, Clinical Cancer Research.

[105]  Y. Miao,et al.  ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation , 2018, Cellular Physiology and Biochemistry.

[106]  Michael L. Gatza,et al.  An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer , 2014, Nature Genetics.

[107]  Jonas Korlach,et al.  The birth of the Epitranscriptome: deciphering the function of RNA modifications , 2012, Genome Biology.

[108]  J. Saurin,et al.  p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer , 2013, Cancer Cell.

[109]  J. Coller,et al.  Structural and molecular mechanisms for the control of eukaryotic 5′–3′ mRNA decay , 2018, Nature Structural & Molecular Biology.

[110]  P. Alam.  ‘A’ , 2021, Composites Engineering: An A–Z Guide.

[111]  Zhifu Sun,et al.  Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy , 2011, Clinical Cancer Research.

[112]  Olivier Elemento,et al.  Reversible methylation of m6Am in the 5′ cap controls mRNA stability , 2016, Nature.

[113]  A. Feuchtinger,et al.  Mitochondrial Alkbh1 localizes to mtRNA granules and its knockdown induces the mitochondrial UPR in humans and C. elegans , 2019, Journal of Cell Science.

[114]  Maurizio Pellecchia,et al.  ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. , 2016, Cell stem cell.

[115]  Liping Xie,et al.  Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels , 2017, Oncotarget.

[116]  V. Cowling,et al.  Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells , 2019, Open Biology.

[117]  Gang Chen,et al.  Overexpression of the fat mass and obesity associated gene (FTO) in breast cancer and its clinical implications. , 2015, International journal of clinical and experimental pathology.